Congress Should Focus On PBMs If Serious Abt. Drug Prices

Prescription drug pricing has a very odd and confusing structure.  Market-based pricing isn’t a feature of the current system. And, what people may not understand is that pharmacy benefit managers (PBMs) are also re-imbursed in a very strange manner. PBMs are currently paid based on the size of the discount they achieve for insurance companies – and, therefore, the employers who offer these insurance plans to their employees. While this seems straightforward, it actually creates upward pressure on prices for patients and families.

 

Read Full Article »


Comment
Show comments Hide Comments


Related Articles

Market Overview
Search Stock Quotes